$33M sweet spot round size
Most of their 22 investments are in rounds between $14M and $60M
2012
GreenLight Biosciences, Inc. raised $126M on February 3, 2022
Investors: Pura Vida Investments, S2G Ventures, Morningside Venture Capital 晨兴资本, Spruce Capital Partners, LLC and Xeraya Capital
OncoMyx Therapeutics raised $50M on December 9, 2021
Investors: Delos Capital, Korea Investment Partners, LYZZ CAPITAL, City Hill Ventures, Madison Partners, Lumira Ventures, B Capital Group and Xeraya Capital
Undisclosed raised $50M on December 8, 2021
Investors: Delos Capital, Korea Investment Partners, B Capital Group, Lumira Ventures, LYZZ CAPITAL, Madison Partners, City Hill Ventures and Xeraya Capital
Imago BioSciences, Inc. raised $80M on November 19, 2020
Investors: Omega Funds, Greenspring Associates, Kingdon Capital Management, Irving Investors, Surveyor Capital, T. Rowe Price and Xeraya Capital
InterVenn Biosciences raised $34M on November 16, 2020
Investors: Amplify Partners, Anzu Partners, True Ventures, Genoa Ventures and Xeraya Capital
Congenica raised $50M on November 9, 2020
Investors: Cambridge Innovation Capital plc, Future Planet Capital, 普华资本, IDO Investments - Oman Investment Authority, Parkwalk Advisors, Tencent and Xeraya Capital
Rapid Micro Biosystems raised $120M on May 20, 2020
Investors: Longitude Capital, Asahi KASEI Medical Europe GmbH, Endeavour Vision and Xeraya Capital
GreenLight Biosciences, Inc. raised $17M on May 12, 2020
Investors: Flu Lab and Xeraya Capital
Aria CV, Inc. raised $31M on February 25, 2020
Investors: Frontcourt Group, Catalyst Health Ventures, Brightstone Venture Capital, BioStar Ventures, Longview Ventures and Xeraya Capital
P2 Science, Inc. raised $12M on January 29, 2020
Investors: HG Ventures, Ironwood Capital, Elm Street Ventures, CHANEL, Advantage Capital and Xeraya Capital